7Rosenberg L. Pancreatic cancer: a review of emerging therapies. Drugs 2000; 59:1071-1089.
8Fromowitz FB, Viola-MV, Chao S, Oravez S, Mishriki Y, Finkel G, Grimson R, Lundy J. ras p21 expression in the progression of breast cancer. Hum Pathol 1987; 18:1268-1275.
9Bartkova J, Lukas J, Strauss M, Bartek J. Cell cycle-related variation and tissue-restricted expression of human cyclin D1 protein, J Pathol 1994; 172: 237-245.
10Motokura T, Yi HF, Kronenberg HM, McBride OW, Arnold A. Assignment of the human cyclin D3 gene (CCND3) to chromosome 6p----q13. Cytogenet Cell Genet 1992; 61:5-7.
1Chen J H, Faquin W C, Lloyd R V, et al. Clinicopathological and molecular characterization of nine cases of columnar cell variant of papillary thyroid carcinoma[J]. ModPathol, 2011, 24(5):739-749.
2Lee S H, Lee J K, Jin S M, et al. Expression of cell-cycle regula- tors(cyclinD1, cyclinE)in papillary thyroid carcinomar[J]. Otolaryn- gel Head Neck Surg, 2010, 142(3):332-337.
3Pap Z, Pvai Z, Dnes L, et al. CyclinD1 and p27 expression as prognostic factor in papillary thyroid carcinoma[J]. Croat Med, 2010, 49(4):643-649.
4Lin Y, Peng S, Yu H, et al. RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of hu- man ovarian cancer cells[J].Med Oncol, 2011, 29(1):311-317.
